A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients - Trial NCT06237777
Access comprehensive clinical trial information for NCT06237777 through Pure Global AI's free database. This Phase 1 trial is sponsored by Wang Min and is currently Recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 18 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Wang Min
Eye & ENT Hospital of Fudan University
Timeline & Enrollment
Phase 1
Jan 01, 2024
Jan 01, 2026
Primary Outcome
Type, severity, and incidence of ocular and systemic AEs,Incidence of DLT
Summary
This is a clinical study to evaluate the safety, tolerability and initial efficacy of SKG0106
 intravitreal injection in diabetic macular edema (DME) patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06237777
Non-Device Trial